Peptide Vaccine

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth M. Gaughan, Craig L. Slingluff

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 163; DOI: 10.1186/s40425-019-0625-x
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
Jonathan A. Trujillo, Jason J. Luke, Yuanyuan Zha, Jeremy P. Segal, Lauren L. Ritterhouse, Stefani Spranger, Karen Matijevich, Thomas F. Gajewski

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 295; DOI: 10.1186/s40425-019-0780-0
Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
Doreen Jackson, Na Qiao, Julia M Greene, Diane Hale, John Berry, Alfred Trappey, Timothy Vreeland, Guy Clifton, Nuhad Ibrahim, Annie Toms, George E Peoples, Elizabeth A Mittendorf

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P156; DOI: 10.1186/2051-1426-3-S2-P156
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
Eleftheria A Anastasopoulou, Panagiotis Tzonis, Sotirios P Fortis, Louisa Mahaira, Christoforos Vaxevanis, Alexandros Ardavanis, Elizabeth A Mittendorf, George E Peoples, Constantin N Baxevanis, Michael Papamichail, Sonia A Perez

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P427; DOI: 10.1186/2051-1426-3-S2-P427
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
Julia Greene, Erika Schneble, John Berry, Alfred Trappey, Timothy Vreeland, Guy Clifton, William McGuire, George Maxwell, Sathibalan Ponniah, George Peoples

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P74; DOI: 10.1186/2051-1426-2-S3-P74
Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
Julia Greene, Erika Schneble, Jonathan Martin, Maddie Flores, Alfred Trappey, John Berry, Timothy Vreeland, Diane Hale, Guy Clifton, Sonia A Perez, Michael Papamichail, George Peoples, Elizabeth Mittendorf, Sathibalan Ponniah

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P90; DOI: 10.1186/2051-1426-2-S3-P90
Induction and isolation of tumor antigen-specific CD4+ T lymphocytes using sorting signal directed MHC class-II expression
Christian Ellinger, Carina Wehner, Susanne Wilde, Dolores J Schendel, Slavoljub Milosevic

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P6; DOI: 10.1186/2051-1426-1-S1-P6
Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
Erika J Schneble, John S Berry, Alfred F Trappey, Timothy J Vreeland, Diane F Hale, Alan K Sears, Guy T Clifton, Sathibalan Ponniah, Nathan M Shumway, Elizabeth A Mittendorf, George E Peoples

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P236; DOI: 10.1186/2051-1426-1-S1-P236
Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients
John S Berry, Erika J Schneble, Alfred F Trappey, Timothy J Vreeland, Guy T Clifton, Diane F Hale, Alan K Sears, Sathibalan Ponniah, Elizabeth A Mittendorf, George E Peoples

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P200; DOI: 10.1186/2051-1426-1-S1-P200
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Anne Letsch, Carmen Scheibenbogen, Antonia Busse, Sebastian Ochsenreither, Igor Wolfgang Blau, Claudia Baldus, Eckhard Thiel, Ulrich Keilholz

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P223; DOI: 10.1186/2051-1426-1-S1-P223

Log in using your username and password

Main menu

Log in using your username and password

You are here

Peptide Vaccine